INSULIN DELIVERY USING NEW LILLY 3 0 ML DISPOSABLE PEN DEVICE
$0M01FY2000RRNIH
University Of North Carolina Chapel Hill, Chapel Hill NC
Investigators
Linked publications & trials
Paper 38599670Paper 38236978Paper 38160309Paper 37910437Paper 36738421Paper 36691838Paper 36540980Paper 36396267Paper 35582911Paper 34998275Paper 34911705Paper 34841560Paper 34453454Paper 34370895Paper 34042329Paper 33901188Paper 33591619Paper 33152181Paper 33066718Paper 32813314Paper 32773474Paper 31631584Paper 31498512Paper 31134052Paper 30864331Paper 30771242Paper 30642925Paper 30481467Paper 29847509Paper 29461980Paper 29361147Paper 29316357Paper 29273092Paper 29218904Paper 29193883Paper 29171837Paper 29135907Paper 29099608Paper 28989944Paper 28264744Paper 28225043Paper 28215371Paper 28099408Paper 28098838Paper 27524847Paper 27509247Paper 26991067Paper 26776173Paper 26575943Paper 26270672Paper 26230332Paper 26180834Paper 26148204Paper 25959858Paper 25933197Paper 25884002Paper 25778456Paper 25727984Paper 25461247Paper 25415421Paper 25377444Paper 25257199Paper 25199974Paper 25159623Paper 25157810Paper 25109932Paper 25079398Paper 24999039Paper 24925880Paper 24922104Paper 24920497Paper 24834926Paper 24729586Paper 24713880Paper 24707468Paper 24702779Paper 24692585Paper 24671709Paper 24659368Paper 24602083Paper 24577601Paper 24568613Paper 24557078Paper 24548980Paper 24531909Paper 24509873Paper 24360345Paper 24300310Paper 24260125Paper 24253247Paper 24231024Paper 24166793Paper 24147920Paper 24144899Paper 24038489Paper 24010879Paper 23982189Paper 23973010Paper 23950187Paper 23944767
Abstract
The purpose of the study is to determine patient acceptance of the 3.0 ml pen device as a method of injecting insulin, the safety of this disposable pen device, if this pen device will aid in initiating insulin therapy in patients just starting insulin therapy, and the change in hemoglobin A1c during use of this disposable pen device.
View original record on NIH RePORTER →